These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28219253)

  • 21. 5-Fluorouracil acetic acid/beta-cyclodextrin conjugates: drug release behavior in enzymatic and rat cecal media.
    Udo K; Hokonohara K; Motoyama K; Arima H; Hirayama F; Uekama K
    Int J Pharm; 2010 Mar; 388(1-2):95-100. PubMed ID: 20036722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs.
    Zhang C; Qu G; Sun Y; Yang T; Yao Z; Shen W; Shen Z; Ding Q; Zhou H; Ping Q
    Eur J Pharm Sci; 2008 Apr; 33(4-5):415-23. PubMed ID: 18337069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
    Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
    J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles.
    Dangi R; Hurkat P; Jain A; Shilpi S; Jain A; Gulbake A; Jain SK
    J Microencapsul; 2014; 31(5):479-87. PubMed ID: 24697169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
    Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
    Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
    Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
    Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
    Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
    J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
    Yan C; Gu J; Guo Y; Chen D
    Yakugaku Zasshi; 2010 Jun; 130(6):801-4. PubMed ID: 20519858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
    Anitha A; Chennazhi KP; Nair SV; Jayakumar R
    J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation of 5-fluorouracil encapsulated in amphiphilic polysaccharide nano-micelles and its killing effect on hepatocarcinoma cell line HepG2].
    Zhou JJ; Chen RF; Tang QB; Zhou QB; Lu HW; Wang J
    Ai Zheng; 2006 Dec; 25(12):1459-63. PubMed ID: 17166367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H; Ogura K; Kato A; Takubo H; Watabe T
    J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.
    Zhu XL; Du YZ; Yu RS; Liu P; Shi D; Chen Y; Wang Y; Huang FF
    Int J Mol Sci; 2013 Jul; 14(8):15755-66. PubMed ID: 23899789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
    Petrov RA; Mefedova SR; Yamansarov EY; Maklakova SY; Grishin DA; Lopatukhina EV; Burenina OY; Lopukhov AV; Kovalev SV; Timchenko YV; Ondar EE; Ivanenkov YA; Evteev SA; Vaneev AN; Timoshenko RV; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
    Mol Pharm; 2021 Jan; 18(1):461-468. PubMed ID: 33264010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabrication and characterization of a folic acid-bound 5-fluorouracil loaded quantum dot system for hepatocellular carcinoma targeted therapy.
    Shi X; He D; Tang G; Tang Q; Xiong R; Ouyang H; Yu CY
    RSC Adv; 2018 May; 8(35):19868-19878. PubMed ID: 35541013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
    Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M
    J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.